197 related articles for article (PubMed ID: 30161003)
1. Rationale for the use of metronomic chemotherapy in gastrointestinal cancer.
Filippi R; Lombardi P; Depetris I; Fenocchio E; Quarà V; Chilà G; Aglietta M; Leone F
Expert Opin Pharmacother; 2018 Sep; 19(13):1451-1463. PubMed ID: 30161003
[TBL] [Abstract][Full Text] [Related]
2. Metronomic chemotherapy for cancer treatment: a decade of clinical studies.
Romiti A; Cox MC; Sarcina I; Di Rocco R; D'Antonio C; Barucca V; Marchetti P
Cancer Chemother Pharmacol; 2013 Jul; 72(1):13-33. PubMed ID: 23475105
[TBL] [Abstract][Full Text] [Related]
3. The potential clinical promise of 'multimodality' metronomic chemotherapy revealed by preclinical studies of metastatic disease.
Kerbel RS; Shaked Y
Cancer Lett; 2017 Aug; 400():293-304. PubMed ID: 28202353
[TBL] [Abstract][Full Text] [Related]
4. A multitargeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer.
Pietras K; Hanahan D
J Clin Oncol; 2005 Feb; 23(5):939-52. PubMed ID: 15557593
[TBL] [Abstract][Full Text] [Related]
5. A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment.
Kerbel RS
Cancer J; 2015; 21(4):274-83. PubMed ID: 26222079
[TBL] [Abstract][Full Text] [Related]
6. Metronomic Chemotherapy for Metastatic Breast Cancer.
Krajnak S; Battista MJ; Hasenburg A; Schmidt M
Oncol Res Treat; 2022; 45(1-2):12-17. PubMed ID: 34794154
[TBL] [Abstract][Full Text] [Related]
7. Metronomic chemotherapy enhances the efficacy of antivascular therapy in ovarian cancer.
Kamat AA; Kim TJ; Landen CN; Lu C; Han LY; Lin YG; Merritt WM; Thaker PH; Gershenson DM; Bischoff FZ; Heymach JV; Jaffe RB; Coleman RL; Sood AK
Cancer Res; 2007 Jan; 67(1):281-8. PubMed ID: 17210709
[TBL] [Abstract][Full Text] [Related]
8. Metronomics chemotherapy: time for computational decision support.
Barbolosi D; Ciccolini J; Meille C; Elharrar X; Faivre C; Lacarelle B; André N; Barlesi F
Cancer Chemother Pharmacol; 2014 Sep; 74(3):647-52. PubMed ID: 25082520
[TBL] [Abstract][Full Text] [Related]
9. Metronomic low-dose chemotherapy as antiangiogenic therapeutic strategy for cancer.
Gille J; Spieth K; Kaufmann R
J Dtsch Dermatol Ges; 2005 Jan; 3(1):26-32. PubMed ID: 16353746
[TBL] [Abstract][Full Text] [Related]
10. Metronomic chemotherapy.
Mutsaers AJ
Top Companion Anim Med; 2009 Aug; 24(3):137-43. PubMed ID: 19732732
[TBL] [Abstract][Full Text] [Related]
11. Metronomic chemotherapy: new rationale for new directions.
Pasquier E; Kavallaris M; André N
Nat Rev Clin Oncol; 2010 Aug; 7(8):455-65. PubMed ID: 20531380
[TBL] [Abstract][Full Text] [Related]
12. Association Between Proton Pump Inhibitors and Metronomic Capecitabine as Salvage Treatment for Patients With Advanced Gastrointestinal Tumors: A Randomized Phase II Trial.
Marchetti P; Milano A; D'Antonio C; Romiti A; Falcone R; Roberto M; Fais S
Clin Colorectal Cancer; 2016 Dec; 15(4):377-380. PubMed ID: 27435761
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of metronomic chemotherapy: a neglected but crucial aspect.
Bocci G; Kerbel RS
Nat Rev Clin Oncol; 2016 Nov; 13(11):659-673. PubMed ID: 27184418
[TBL] [Abstract][Full Text] [Related]
14. [Metronomic chemotherapy in 2011: update and perspectives].
Benbrahim Z; Massard C; El Mesbahi O
Bull Cancer; 2011 Dec; 98(12):1447-54. PubMed ID: 22146261
[TBL] [Abstract][Full Text] [Related]
15. A metronomic schedule as salvage chemotherapy for upper gastrointestinal tract cancer.
Roberto M; Romiti A; Onesti CE; D'Antonio C; Milano A; Falcone R; Barucca V; Palombi L; Righini R; Marchetti P
Anticancer Drugs; 2016 Feb; 27(2):106-11. PubMed ID: 26473528
[TBL] [Abstract][Full Text] [Related]
16. [Antiangiogenic therapy for gastrointestinal tumors].
Lakatos G; Tulassay Z
Orv Hetil; 2008 Dec; 149(49):2317-24. PubMed ID: 19042183
[TBL] [Abstract][Full Text] [Related]
17. Metronomic chemotherapy in metastatic colorectal cancer.
Woo IS; Jung YH
Cancer Lett; 2017 Aug; 400():319-324. PubMed ID: 28274890
[TBL] [Abstract][Full Text] [Related]
18. Metronomic chemotherapy: Back to the future!
André N; Padovani L; Verschuur A
Drug News Perspect; 2010 Mar; 23(2):143-51. PubMed ID: 20369080
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamic biomarkers in metronomic chemotherapy: multiplex cytokine measurements in gastrointestinal cancer patients.
Valenzuela P; Oaxaca D; Di Desidero T; Parra K; Rodriguez G; Manciu M; Allegrini G; Falcone A; Bocci G; Kirken RA; Francia G
Clin Exp Med; 2021 Feb; 21(1):149-159. PubMed ID: 33048259
[TBL] [Abstract][Full Text] [Related]
20. Resistance to metronomic chemotherapy and ways to overcome it.
Riesco-Martinez M; Parra K; Saluja R; Francia G; Emmenegger U
Cancer Lett; 2017 Aug; 400():311-318. PubMed ID: 28259819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]